Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA]: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
Breast cancer	1
Cancer	1
Carcinoma	1
Lung cancer	1
MSI-High	1
Melanoma	1
Non Small Cell Lung Cancer	1
Renal Cell Carcinoma	1
Solid Tumor	1
Squamous Cell Carcinoma of the Head and Neck	1
Triple-negative Breast Cancer	1

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
NCT04787042 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations

1 recruiting trial across 11 conditions.

No. For the full record, search ClinicalTrials.gov.